After finishing at $0.10 in the prior trading day, Kintara Therapeutics Inc (NASDAQ: KTRA) closed at $0.10, down -5.77%. In other words, the price has decreased by -$0.0060 from its previous closing price. On the day, 3595983 shares were traded.
Ratios:
Our goal is to gain a better understanding of KTRA by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.63 and its Current Ratio is at 0.63.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, KTRA now has a Market Capitalization of 3.83M and an Enterprise Value of 13.42M.
Stock Price History:
Over the past 52 weeks, KTRA has reached a high of $5.98, while it has fallen to a 52-week low of $0.08. The 50-Day Moving Average of the stock is 0.1056, while the 200-Day Moving Average is calculated to be 1.9479.
Shares Statistics:
The stock has traded on average 13.69M shares per day over the past 3-months and 6.16M shares per day over the last 10 days, according to various share statistics. A total of 39.04M shares are outstanding, with a floating share count of 38.96M. Insiders hold about 0.19% of the company’s shares, while institutions hold 0.62% stake in the company. Shares short for KTRA as of Mar 15, 2024 were 2.2M with a Short Ratio of 0.16, compared to 411.08k on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 5.63% and a Short% of Float of 5.63%.
Earnings Estimates
Its stock is currently analyzed by 0 different market analysts. On average, analysts expect EPS of $0 for the current quarter, with a high estimate of $0 and a low estimate of $0, while EPS last year was -$3.5. The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between -$0.46 and -$0.46 for the fiscal current year, implying an average EPS of -$0.46. EPS for the following year is -$0.38, with 1 analysts recommending between -$0.38 and -$0.38.
